Optimizing Liver Transplant Allocation for Hepatocellular Carcinoma: Development and Validation of a Survival Benefit‐Based Model
The HCC-LTSB model accurately predicted the survival benefit provided by LT in candidates listed with unresectable HCC within UNOS criteria.
Authors
- Stalin Dharmayan
- Eishan Ashwat (ORCID: https://orcid.org/0000-0002-2413-4463)
- Amaan Rahman
- Stela Celaj (ORCID: https://orcid.org/0000-0002-0305-2012)
- Vrishketan Sethi (ORCID: https://orcid.org/0000-0001-5467-9811)
- Jaideep Behari (ORCID: https://orcid.org/0000-0001-8077-5137)
- H. Liu
- Shwe Phyo Han (ORCID: https://orcid.org/0000-0002-8995-4083)
- Michele Molinari (ORCID: https://orcid.org/0000-0002-9763-6253)
- Isabel Neckermann (ORCID: https://orcid.org/0000-0003-0152-9355)
- Xingyu Zhang (ORCID: https://orcid.org/0000-0001-8108-1997)
- Abiha Abdullah
- Timothy Fokken
- Charbel Elias
- Christopher Kaltenmeier
- Jason Mial‐Anthony
- Subedi Sabin
- Packiaraj Godwin
Institutions
- University of Pittsburgh (US)
- Georgetown University (US)
- Methodist Hospital (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1111/ctr.70488
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- Minneapolis Medical Research Foundation
- Health Resources and Services Administration